Weimin Xie

机构：Hengyang Normal University, Guangxi Medical University, Ministry of Education, Hengyang Academy of Agricultural Sciences, Tumor Hospital of Guangxi Medical University · ORCID：0000-0002-3821-7446

发表论文 94 篇 · 总被引 1874 次 · h-index 23

代表论文

• Global, regional, and national burden of ovarian cancer, 1990–2021, and projections to 2050: a cross-sectional analysis of the Global Burden of Disease Study 2021 (2025 · International Journal of Surgery · 被引 12)
• Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial (2025 · The Lancet Oncology · 被引 8)
• Laparoendoscopic single site myomectomy versus conventional laparoscopic myomectomy for uterine myomas: a systematic review and meta-analysis (2025 · International Journal of Surgery · 被引 5)
• Does vertical supervision enhance labor productivity? Evidence from China’s central environmental protection inspection (2025 · Humanities and Social Sciences Communications · 被引 4)
• Preliminary efficacy and safety of TQB2102 in patients with HER2 low-expressing recurrent/metastatic breast cancer: Results from a phase 1b study. (2025 · Journal of Clinical Oncology · 被引 2)
• Single-atom nanozymes for antitumor catalytic therapy: structural engineering, catalytic mechanism, and advanced therapeutic strategies (2026 · Chemical Communications · 被引 1)